Trademark: 97653516
Word
INPEFA. SOTAGLIFLOZIN TABLETS
Status Date
Tuesday, August 15, 2023
Registration Number
7141092
Registration Date
Tuesday, August 15, 2023
Filing Date
Friday, October 28, 2022
Published for Opposition
Tuesday, January 24, 2023
5 Pharmaceutical preparations for the treatment or prevention of heart failure
The mark consists of stlylized phrase "inpefa. sotagliflozin tablets".
Color is not claimed as a feature of the mark.
"TABLETS"
Aug 15, 2023
Notice Of Registration Confirmation Emailed
Aug 15, 2023
Registered-Principal Register
Jul 11, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 10, 2023
Allowed Principal Register - Sou Accepted
Jun 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 16, 2023
Statement Of Use Processing Complete
Jun 8, 2023
Use Amendment Filed
Jun 16, 2023
Sou Extension 1 Granted
Jun 8, 2023
Sou Extension 1 Filed
Jun 16, 2023
Case Assigned To Intent To Use Paralegal
Jun 8, 2023
Sou Teas Extension Received
Jun 8, 2023
Teas Statement Of Use Received
Mar 21, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 24, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2023
Published For Opposition
Jan 4, 2023
Notification Of Notice Of Publication E-Mailed
Dec 21, 2022
Approved For Pub - Principal Register
Dec 7, 2022
Teas/Email Correspondence Entered
Dec 7, 2022
Correspondence Received In Law Office
Dec 7, 2022
Teas Response To Office Action Received
Dec 6, 2022
Notification Of Non-Final Action E-Mailed
Dec 6, 2022
Non-Final Action E-Mailed
Dec 6, 2022
Non-Final Action Written
Nov 29, 2022
Assigned To Examiner
Nov 15, 2022
New Application Office Supplied Data Entered
Nov 1, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
